Companies: 10,795·Total market cap: $144.5T
Compass Therapeutics, Inc.

Compass Therapeutics, Inc.

CMPXNASDAQHealthcare● Active
$2.02
$-0.02(-0.98%)
Market Cap$279338328
P/E Ratio—
52W High$6.88
52W Low$1.61
Overview

Compass Therapeutics, Inc. (CMPX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001738021 · CMPX · NASDAQ · as of Jun 8, 2026

Filing snapshot

349
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-15
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001738021 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-05
Fiscal Year End
Mar 5, 2026
Accession No.
0001171843-26-001337
Primary Document
cmpx20251231_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001738021 · Accession 0001171843-26-001337

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-05-05
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-05-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
10-QQuarterly Report
FORM 10-Q
2026-05-05
View
8-KCurrent Report
FORM 8-K
2026-05-05
View
ARSARS
ARS
2026-04-29
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-29
View
DEF 14AProxy Statement
DEF 14A
2026-04-29
View
8-KCurrent Report
FORM 8-K
2026-04-27
View
S-8Employee Stock Plan Registration
S-8
2026-03-12
View
10-KAnnual Report
FORM 10-K
2026-03-05
View
8-KCurrent Report
FORM 8-K
2026-03-05
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-01-21
View
EFFECTEFFECT
EFFECT
2026-01-07
View
8-KCurrent Report
FORM 8-K
2026-01-06
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-01-05
View
Showing 1–15 of 230 filingsForm 4 / 144 hidden· 349 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001738021  |  Exchange: NASDAQ · Healthcare

Compass Therapeutics, Inc. (NASDAQ: CMPX) has submitted 349 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001738021, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Compass Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Compass Therapeutics, Inc. 10-K was filed on 2026-03-05 for fiscal year ending 2026. Historical CMPX 10-K annual reports are available from 2018 through 2026.

Investors researching Compass Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
KALV SEC Filings →CRVS SEC Filings →LXRX SEC Filings →OMER SEC Filings →FDMT SEC Filings →OCGN SEC Filings →MNPR SEC Filings →BCYC SEC Filings →
→ CMPX Financials→ CMPX Earnings→ CMPX Insider Trades

Frequently Asked Questions

CMPX SEC Filings · 8 questions

Compass Therapeutics, Inc. (CMPX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 349 filings and access original documents at no cost. Compass Therapeutics, Inc.'s CIK is 0001738021.

CMPX SEC filingsCompass Therapeutics, Inc. SEC documentsfind CMPX 10-K